Global biopharmaceutical company
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings;
FY2020 appropriations for Labor-HHS, CJS and Interior (Indian Health Service) bills; CREATE Opportunities Act (S. 1983/H.R. 3496) Maintain six protected classes for depression and schizophrenia under Medicare Part D Awareness of the need for access to all FDA-approved medications

Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments

Initiatives to promote the use of relapse prevention post detoxification
ALC - Alcohol and Drug Abuse MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SPLITOAK STRATEGIES LLC
300 New Jersey Avenue, NW, Suite 900, Washington, DC, 20001, US
SARAH KUEHL EGGE (1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction) SARAH KUEHL EGGE SARAH KUEHL EGGE
1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction